Behind Chunyu Healthcare's (00108) revenue increase of more than 30%: a new transformation in AI intelligent medical strategy transformation

In December 2025, Guo Rui Life revealed a transaction plan to acquire 78.3% of Dr. Chunyu's shares, which once made the company a popular investment target in the Hong Kong stock market.

At the time, the market believed that through this cross-border acquisition, Guorui Life officially entered a new stage of two-wheel drive development of “high-quality property assets+AI digital medical services”. It can not only smooth out the cyclical fluctuations in the traditional property investment business, but also promote the expansion of the company's core assets from a single physical space to a scenario-based infrastructure that can carry the health needs of hundreds of millions of users, and further tap the growth potential of the digital medical circuit.

In 2026, the acquisition process progressed in an orderly manner, and the delivery was completed in March; in July, the listed company officially changed its name to Chunyu Medical. On August 31, Chunyu Medical announced its 2026 interim results and handed over a questionnaire to the market with a successful test transformation.

Intelligent medical services are blossoming more and more, driving high revenue growth

Financial reports show that in the first half of 2026, Chunyu Medical achieved a total revenue of HK$223 million, an increase of about 30.7% over the previous year. Shareholders should have lost HK$70.6 million during the period due to other factors such as rising operating costs, increased financial expenses, and increased employee benefit expenses.

In terms of business structure, the company's intelligent medical service segment achieved revenue of HK$655.76 million, and the property investment and operation management segment achieved revenue of HK$158 million. What is more noteworthy is that the smart medical service business sector achieved a profit of HK$127.66 million in the first half of the year, effectively hedging cyclical fluctuations in the property investment operation and management business.

After the delivery was completed in March 2026, the listed company officially took over Dr. Chunyu's operations. Management promotes operational improvements around improving the quality of existing business and expanding new circuits to drive business revenue expansion.

The Zhitong Finance App learned that at the business level, Chunyu Medical introduced cooperative resources from overseas insurance institutions, expanded the sales scale of health rights cards, brought in revenue of more than 9.3 million yuan, stabilized the basic diagnosis and treatment business market, and maintained diagnosis and treatment revenue at the level of the previous year. At the same time, it implemented the incentive policy that was not implemented in 2025, mobilized the initiative of the business team, and achieved breakthroughs in digital marketing and medical research-related businesses, contributing more than HK$35 million in revenue growth. In addition, the company introduced a new business model, arranged self-marketing and sales of Chinese medicine tablets, and achieved sales revenue of 410,000 HKD of its own medicines. Overall, the first half of this year saw an increase of HK$38.3 million in revenue over the same period last year.

This series of business actions can be converted into actual revenue, and is rooted in Dr. Chunyu's 15 years of experience with the platform's capabilities. As a pioneer in the domestic Internet medical industry, the platform has accumulated nearly 200 million registered users, over 700,000 registered physicians, and kept about 300 million user health files. The self-developed AI medical model “Chunyu Huiwen” has also been implemented in practical scenarios.

The platform can provide 7×24 hour online consultation, video consultation, consultation with famous doctors, etc.; relies on AI capabilities to achieve intelligent guidance, auxiliary diagnosis, health risk assessment; serial electronic prescriptions, online drug purchase, door-to-door drug delivery, chronic disease management, rehabilitation care and personal file management to establish a complete service loop of “consultation-prescription-drugs-rehabilitation”.

Compared to incubating the medical business from scratch, this acquisition allows listed companies to directly obtain a mature business system that has been proven by the market. However, the company's next stage of growth largely depends on whether AI technology can be transformed into service capabilities that can be delivered on a large scale.

The Zhitong Finance App learned that around AI infrastructure construction, Chunyu Medical is building a unified technology foundation that can be reused, covering the fields of medical expertise, medical data management, iterative application of models, and medical agents (agents). On the premise of complying with the law, obtaining necessary authorizations, and strictly adhering to data security, the platform promotes the structuring of health files, accumulates specialist medical knowledge, and introduces clinical experts to participate in model effect evaluation, continuously improving the suitability and reliability of AI in real medical scenarios. Based on this, we will open up links such as pre-diagnosis, medical history sorting, clinical support decision-making, and post-diagnosis follow-up, and establish a “doctor-led, AI-assisted” standardized service link, which not only improves the efficiency of doctors' treatment, but also guarantees the stability of the efficiency and quality of medical services, laying the foundation for business scale expansion.

Through an already completed business foundation and superimposed AI capabilities, Chunyu Medical will further broaden the growth boundaries of the G-side, C-side, and B-side: the government side will replicate the mature G2C public health model, deepen collaboration with local governments and community health service centers, implement public health projects such as electronic health files and chronic disease follow-up, expand government orders, and explore the “platform building+continuous operation” city-level public health operation model to accumulate core capabilities to evolve into city-level smart medical operators.

The C-side focuses on the whole chain of prevention, diagnosis, treatment, rehabilitation and follow-up, refining recurring revenue products such as chronic disease service packages and health management subscriptions. It is expected that AI health assistants can be used to undertake health consultations, medical navigation, medication reminders, and chronic disease follow-up, and seamlessly transfer medical practitioners when necessary to continuously enhance the life cycle value of users. The B-side continues to export B2D2C services such as digital marketing, real-world research, and patient recruitment management to pharmaceutical companies and insurance institutions. It is expected to deliver a combination of medical resources and intelligent tools, and also export standardized technology products such as doctor assistants and patient follow-up management to medical institutions, expand the revenue revenue model of “C-end medical services+B-side industry empowerment”, optimize the revenue structure, increase the share of recurring revenue, and release the incremental effect of the platform's marginal cost.

Two-way empowerment of property medical care, outlining a new picture of “medical collaboration”

Looking back at Chunyu Medical's development history, the company has long been deeply involved in the property sector. Its business covers property management, property development and investment, and is located in many parts of China, the United States and the United Kingdom. The real estate industry has entered the stage of improving quality and efficiency, and competition in the property industry is shifting to refined operation. The company initiated business structure optimization, actively cultivated a new growth curve, and focused on building a “smart real estate+digital healthcare” integrated ecosystem. The acquisition of Dr. Chunyu was a key gripper to achieve this strategic concept.

The two types of business have natural complementary attributes. They are highly suited to offline physical scenarios and online medical capabilities, and the collaborative layout is progressing steadily. The residential projects managed by the company cover a large number of household customers, and commercial properties reach a large number of office people. Such groups have stable and real health consumption needs. They are high-quality potential users of Internet medical care, which can effectively alleviate the pain points of high customer acquisition costs and insufficient offline penetration in the industry. By embedding medical services into communities and office buildings, service scenarios can be implemented in depth; using the platform's AI technology and massive health files, it is possible to build an intelligent health management system adapted to the property scenario, output personalized health services, and continuously improve user stickiness.

At the same time, Chunyu's mature medical resources have also opened up value-added space for traditional property services. The traditional property business is mainly based on basic services such as security and cleaning. After combining medical services such as online consultation, health monitoring, and chronic disease management, a new “basic property+health value-added service” product system can be built to effectively enhance the value of property projects and household experience, and promote the transformation and upgrading of enterprises from traditional property asset management entities to medical technology service providers.

According to the business plan disclosed in this interim report, Chunyu Medical will promote a deep restructuring of the business model, gradually divest inefficient asset-heavy businesses, and focus core resources on the AI intelligent medical circuit. In the future, the company will open up its own property community and Dr. Chunyu's online medical capabilities, turn the community into a health service implementation scenario, and build a health service ecosystem linked online and offline. The company will retain Dr. Chunyu's original core management team, and rely on the offline property scene network to broaden service boundaries, absorb new users, and achieve deep integration of multiple resources.

This construction direction will also effectively echo the integration of the epitaxial industry. Businesses such as primary care, specialist services, rehabilitation and nursing can provide richer real application scenarios for AI technology implementation; unified AI technology capabilities are also expected to drastically reduce the cost of new business access and standardized replication of services, and improve the implementation efficiency of subsequent industrial integration. As technology construction, scenario verification, and commercial operation form a positive cycle, Chunyu Medical is expected to push the revenue structure to gradually expand from traditional medical services to technical services and continuous operation revenue. The long-term value will be reflected mainly in service efficiency, customer contract renewal ability, revenue quality, and the ability to replicate on a large scale across scenarios.

Conclusions

As Internet medical treatment gradually moved from simple online consultations to a new stage of the “technology-data-scenario” trinity, the industry's judgment logic was also iterated. In the past, the market valued user size and traffic growth rate. Today, stable monetization channels, scarce implementation scenarios, and diverse revenue structures, including AI technology infrastructure capabilities, cross-scenario replication capabilities, customer contract renewal and revenue quality, are increasingly the key to determining the long-term vitality of an enterprise.

Faced with this new industry evaluation system, Chunyu Medical handed over the phased management results of transformation, and also completed the initial layout in the above key dimensions. Looking at the broader industrial environment, with the help of the “Healthy China” strategy and the digital economy, the cross-border integration of traditional physical industries and the big health circuit is becoming an important direction for the high-quality development of the Chinese economy. As AI technology continues to sink into people's livelihood and health scenarios, residents' demand for health consumption continues to rise, and the external environment of the industry forms a favorable soil for development. If it can build on the existing business foundation and transform its resource endowments into greater operational effectiveness, Chunyu Medical's investment value is also expected to be re-examined and defined by the market.